Skip to main content

Hematologic Changes with Aging

  • Chapter
  • First Online:
Geriatric Trauma and Critical Care

Abstract

The age-related hematologic changes of older trauma victims include a baseline anemia and hypercoagulability. These patients have less responsive bone marrow and are slower to repopulate cell lines following injury and hemorrhage. Pre-injury medication profiles for older patients will often include at least one anticoagulant, and understanding of its mechanism and reversal can be lifesaving. The geriatric trauma patient is challenging, and knowledge of both natural and iatrogenic hematologic changes is paramount to their care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. MacKenzie EJ, Fowler CJ. Epidemiology. In: Feliciano DV, Moore EE, Mattox KL, editors. Trauma. 6th ed. New York: McGraw Hill; 1996. p. 26–32.

    Google Scholar 

  2. Kannus P, Parkkari J, Koshkinen S, Niemi S, Palvanen M, Jarvinen M, Vuori I. Fall-induced injuries and deaths among older adults. JAMA. 1999;281:1895–9.

    Article  CAS  PubMed  Google Scholar 

  3. Alexander BH, Rivara FP, Wolf ME. The cost and frequency of hospitalization for fall-related injuries in older adults. Am J Public Health. 1992;82:1020–3.

    Article  CAS  PubMed  Google Scholar 

  4. Hill RD. The prevalence of anemia in the over-65’s in a rural practice. Practitioner. 1967;217:963–7.

    Google Scholar 

  5. Myers MA, Saunders CRG, Chalmers DG. The hemoglobin level of fit elderly people. Lancet. 1968;292:261–3.

    Article  Google Scholar 

  6. McLennan WJ, Andrews VGR, Macleod C, Caird FL. Anemia in the elderly. Q J Med. 1973;42:1–13.

    CAS  PubMed  Google Scholar 

  7. Gershoff SN, Brusis OA, Hipolito VN, Huber AM. Studies of the elderly in Boston. The effects of iron fortification on moderately anemic people. Am J Clin Nutr. 1977;30:226–34.

    CAS  PubMed  Google Scholar 

  8. Lipschitz DA, Udupa KB, Milton KY, Thompson CO. Effect of age on hematopoiesis in man. Blood. 1984;63:502–9.

    CAS  PubMed  Google Scholar 

  9. Ershler WB, Sheng S, McKelvey J, Artz AS, Denduluri N, Tecson J, et al. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc. 2005;53:1360–5.

    Article  PubMed  Google Scholar 

  10. Brightwell RF, Crawford GP, Cale JB, Pedler PJ, Bittles AH. Ageing and the haematological profiles of an Australian Community. Ann Hum Biol. 1998;25:1–10.

    Article  CAS  PubMed  Google Scholar 

  11. Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107:2099–107.

    Article  PubMed  Google Scholar 

  12. Hotta T, Hirabayashi N, Utsumi M, Murate T, Yamada H. Age-related changes in the function of hemopoietic stroma in mice. Exp Hematol. 1980;8:933–6.

    CAS  PubMed  Google Scholar 

  13. Harrison DE. Long-term erythropoietic repopulating ability of old, young, and fetal stem cells. J Exp Med. 1983;157:1496–504.

    Article  CAS  PubMed  Google Scholar 

  14. Gross L. Mechanisms of aging in bone marrow stem cells. PLoS Biol. 2007;5:e215.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Woolthuis C, deHaan G, Huls G. Aging of hematopoietic stem cells: intrinsic changes or micro-environment effects? Curr Opin Immunol. 2011;23:512–7.

    Article  CAS  PubMed  Google Scholar 

  16. Pinto A, De Filippi R, Frigeri F, Corazzelli G, Normanno N. Aging and the hemopoietic system. Crit Rev Oncol Hematol. 2003;48:S3–12.

    Article  PubMed  Google Scholar 

  17. Balducci L, Lyman GH. Patients aged ≥70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J Clin Oncol. 2000;18:3558–85.

    Google Scholar 

  18. Gaynor E, Dahlberg S, Fisher R. Factors affecting reduced survival of the elderly with intermediate and high-grade lymphoma: an analysis of SWOG-8516 (INT 0067). Proc Am Soc Clin Oncol. 1994;13:370.

    Google Scholar 

  19. Boggs DR, Patrene KD. Hematopoiesis and the aging III: anemia and a blunted erythropoietic response to hemorrhage in aged mice. Am J Hematol. 1985;19:327–38.

    Article  CAS  PubMed  Google Scholar 

  20. Wu W, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA. 2007;297:2481–7.

    Article  CAS  PubMed  Google Scholar 

  21. Gearhart MM, Luchette FA, Proctor MC, Lutomski DM, Witsken C, James L, et al. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. Surgery. 2000;128:631–40.

    Article  CAS  PubMed  Google Scholar 

  22. Tracy RP, Bovill EG. Thrombosis and cardiovascular risk in the elderly. Arch Pathol Lab Med. 1992;116:1307–12.

    CAS  PubMed  Google Scholar 

  23. Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost. 1985;54:475–9.

    CAS  PubMed  Google Scholar 

  24. Mari D, Mannucci PM, Coppola R, Bottaso B, Bauer KA, Rosenburg RD. Hypercoagulability in centenarians: the paradox of successful aging. Blood. 1995;85:3144–9.

    CAS  PubMed  Google Scholar 

  25. Sagripanti A, Capri A. Natural anticoagulants, aging, and thromboembolism. Exp Gerontol. 1998;33:891–6.

    Article  CAS  PubMed  Google Scholar 

  26. Sakkin PA, Cushman M, Psaty BM, Kuller LH, Bajaj SP, Sabharwal AK, et al. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort. Thromb Haemost. 1998;80:134–9.

    Google Scholar 

  27. Zahavi J, Jones NAG, Leyton J, Dubiel M, Kakkar VV. Enhanced in vivo “platelet reaction” in old healthy individuals. Thromb Res. 1980;17:329–36.

    Article  CAS  PubMed  Google Scholar 

  28. Modesti PA, Fortini A, Abbate R, Gensini GF. Age related changes of platelet prostacyclin receptors in humans. Eur J Clin Invest. 1985;15:204–8.

    Article  CAS  PubMed  Google Scholar 

  29. Bastyr III EJ, Kadrofske MM, Vink AI. Platelet activity and phosphoinositide turnover increases with advancing age. Am J Med. 1990;88:601–6.

    Article  CAS  PubMed  Google Scholar 

  30. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marucci G, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993;70:380–5.

    CAS  PubMed  Google Scholar 

  31. Abbate R, Prisco D, Rostagno C, Boddi M, Gensini GF. Age-related changes in the hemostatic system. Int J Clin Lab Res. 1993;23:1–3.

    Article  CAS  PubMed  Google Scholar 

  32. Yamamoto K, Takeshita K, Kojima T, Takamatsu J, Saito H. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc Res. 2005;66:276–85.

    Article  CAS  PubMed  Google Scholar 

  33. Yamamoto K, Takeshita K, Shimokawa T, Yi H, Isobe K, Loskutoff DJ, et al. Plasminogen activator inhibitor-1 is a major stress-related gene: implications for stress-induced thrombosis in aged individuals. Proc Natl Acad Sci U S A. 2002;99:890–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Konkle BA, Schuster SJ, Kelly MD, Harjes K, Hassestt DE, Bohrer M, et al. Plasminogen activator inhibitor-1 messenger RNA expression is induced in rat hepatocytes in vivo by dexamethasone. Blood. 1992;79:2636–42.

    CAS  PubMed  Google Scholar 

  35. Yamamoto K, Loskutoff DJ. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest. 1996;97:2440–51.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Pignone M, Anderson GK, Binns K, Tilson HH, Weisman SM. Aspirin use among adults aged 40 and older in the United States: results of a national survey. Am J Prev Med. 2007;32:403–7.

    Article  PubMed  Google Scholar 

  37. Clinton P, et al. Pharma Exec 50. May 2010. http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/222010/671415/article.pdf. Accessed 8/1/2012.

  38. Ohm C, Mina A, Howells G, Bair H, Bendick P. Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. J Trauma. 2055;58:518–22.

    Article  Google Scholar 

  39. Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ. Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma. 2008;65:785–8.

    Article  CAS  PubMed  Google Scholar 

  40. Thiele T, Sumnig A, Hron G, Muller C, Althaus K, Schroeder HW, et al. Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. J Thromb Haemost. 2012;10:968–71.

    Article  CAS  PubMed  Google Scholar 

  41. Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG. Platelet mapping and desmopressin reversal of platelet inhibition during emergent carotid endarterectomy. J Cardiothorac Vasc Anesth. 2007;21:851–4.

    Article  PubMed  Google Scholar 

  42. Bansal V, Fortlage D, Lee J, Doucet J, Potenza B, Coimbra R. A new clopidogrel (Plavix) point-of-care assay: rapid determination of antiplatelet activity in trauma patients. J Trauma. 2011;70:65–9.

    Article  CAS  PubMed  Google Scholar 

  43. Bachelani AM, Bautz JT, Sperry JL, Corcos A, Zenati M, Billiar TR, et al. Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury. Surgery. 2011;150:836–43.

    Article  PubMed  Google Scholar 

  44. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155:469–73.

    Article  CAS  PubMed  Google Scholar 

  45. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–5.

    Article  CAS  PubMed  Google Scholar 

  46. Ageno W, Gallus AS, Witkowsky A, Crowther M, Hylek EM, Palareti G, American College of Chest Physicians. Oral anticoagulant therapy and prevention of thrombosis, 9th ed: American College of Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e44s–88.

    Article  CAS  PubMed  Google Scholar 

  47. Mina AA, Bair HA, Howells GA, Bendick PJ. Complications of preinjury warfarin use in the trauma patient. J Trauma. 2003;54:842–7.

    Article  PubMed  Google Scholar 

  48. Kuwashiro T, Yasaka M, Itabashi R, Nakagaki H, Miyashita F, Naritomi H, et al. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage. Cerebrovasc Dis. 2001;31:170–6.

    Article  Google Scholar 

  49. Sarode R, Matevosyan K, Bhagat R, Rutherford C, Madden C, Beshay JE. Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIA cocktail for intracerebral hemorrhage. J Neurosurg. 2012;116:491–7.

    Article  CAS  PubMed  Google Scholar 

  50. DeLoughery TG. Practical aspects of the oral new anticoagulants. Am J Hematol. 2011;86:586–90.

    Article  CAS  PubMed  Google Scholar 

  51. Furie KL, Goldstein LB, Albers GW, Khatri P, Neyens R, Turakhia MP, et al. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:3442–53.

    Article  PubMed  Google Scholar 

  52. Pragst I, Zeitler SH, Doerr B, Kaspereit FJ, Herzog E, Dickneite G, et al. Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model. J Thromb Haemost. 2012;10(9):1841–8.

    Article  CAS  PubMed  Google Scholar 

  53. Fukuda T, Honda Y, Kamisato C, Morishima Y, Shibano T. Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents. Thromb Haemost. 2012;107:253–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter E. Fischer MD, MS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fischer, P.E., DeLoughery, T.G., Schreiber, M.A. (2014). Hematologic Changes with Aging. In: Yelon, J., Luchette, F. (eds) Geriatric Trauma and Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8501-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8501-8_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8500-1

  • Online ISBN: 978-1-4614-8501-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics